Search

everythinglearnresearchcommunity

for

Search:↓

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Men with Kennedy disease have less chance of hair loss.

Kenogen increases with hair loss in women.

Female hair loss linked to metabolic syndrome, not in males.

Hair loss common in Norwegian men, affecting self-esteem and life quality.

Congenital Triangular Alopecia is a rare, non-scarring hair loss that can be surgically treated in females for cosmetic reasons.

Aging alone barely affects the number of hair follicles, meaning hair loss is minimal without other conditions like androgenetic alopecia.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Traction may not be the only cause of cicatricial marginal alopecia.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.